Literature DB >> 30588620

Adherence to the mediterranean diet and lymphoma risk in the european prospective investigation into cancer and nutrition.

Marta Solans1,2,3, Yolanda Benavente1,4, Marc Saez1,2, Antonio Agudo5, Sabine Naudin6, Fatemeh Saberi Hosnijeh7,8, Hwayoung Noh6, Heinz Freisling6, Pietro Ferrari6, Caroline Besson9,10,11, Yahya Mahamat-Saleh10,11, Marie-Christine Boutron-Ruault10,11, Tilman Kühn12, Rudolf Kaaks12, Heiner Boeing13, Cristina Lasheras14, Miguel Rodríguez-Barranco1,15, Pilar Amiano1,16, Jose Maria Huerta1,17, Aurelio Barricarte1,18,19, Julie A Schmidt20, Paolo Vineis21, Elio Riboli22, Antonia Trichopoulou23,24, Christina Bamia23,24, Eleni Peppa23,24, Giovanna Masala25, Claudia Agnoli26, Rosario Tumino27, Carlotta Sacerdote28, Salvatore Panico29, Guri Skeie30, Elisabete Weiderpass30,31,32,33, Mats Jerkeman34, Ulrika Ericson34, Florentin Späth35, Lena Maria Nilsson36, Christina C Dahm37, Kim Overvad37, Anne Katrine Bolvig38, Anne Tjønneland38,39, Silvia de Sanjose1,4,40, Genevieve Buckland41, Roel Vermeulen7, Alexandra Nieters42, Delphine Casabonne1,4.   

Abstract

There is a growing evidence of the protective role of the Mediterranean diet (MD) on cancer. However, no prospective study has yet investigated its influence on lymphoma. We evaluated the association between adherence to the MD and risk of lymphoma and its subtypes in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. The analysis included 476,160 participants, recruited from 10 European countries between 1991 and 2001. Adherence to the MD was estimated through the adapted relative MD (arMED) score excluding alcohol. Cox proportional hazards regression models were used while adjusting for potential confounders. During an average follow-up of 13.9 years, 3,136 lymphomas (135 Hodgkin lymphoma [HL], 2,606 non-HL and 395 lymphoma not otherwise specified) were identified. Overall, a 1-unit increase in the arMED score was associated with a 2% lower risk of lymphoma (95% CI: 0.97; 1.00, p-trend = 0.03) while a statistically nonsignificant inverse association between a high versus low arMED score and risk of lymphoma was observed (hazard ratio [HR]: 0.91 [95% CI 0.80; 1.03], p-trend = 0.12). Analyses by lymphoma subtype did not reveal any statistically significant associations. Albeit with small numbers of cases (N = 135), a suggestive inverse association was found for HL (HR 1-unit increase = 0.93 [95% CI: 0.86; 1.01], p-trend = 0.07). However, the study may have lacked statistical power to detect small effect sizes for lymphoma subtype. Our findings suggest that an increasing arMED score was inversely related to the risk of overall lymphoma in EPIC but not by subtypes. Further large prospective studies are warranted to confirm these findings.
© 2018 UICC.

Entities:  

Keywords:  Europe; Mediterranean diet; lymphoma; prospective studies; risk

Mesh:

Year:  2019        PMID: 30588620     DOI: 10.1002/ijc.32091

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  3 in total

Review 1.  How to Tackle the Relationship between Autoimmune Diseases and Diet: Well Begun Is Half-Done.

Authors:  Camilla Barbero Mazzucca; Davide Raineri; Giuseppe Cappellano; Annalisa Chiocchetti
Journal:  Nutrients       Date:  2021-11-05       Impact factor: 5.717

2.  An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer.

Authors:  Jakub Morze; Anna Danielewicz; Katarzyna Przybyłowicz; Hongmei Zeng; Georg Hoffmann; Lukas Schwingshackl
Journal:  Eur J Nutr       Date:  2020-08-08       Impact factor: 5.614

3.  Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.

Authors:  Fatemeh Saberi Hosnijeh; Delphine Casabonne; Alexandra Nieters; Marta Solans; Sabine Naudin; Pietro Ferrari; James D Mckay; Yolanda Benavente; Elisabete Weiderpass; Heinz Freisling; Gianluca Severi; Marie-Christine Boutron Ruault; Caroline Besson; Claudia Agnoli; Giovanna Masala; Carlotta Sacerdote; Rosario Tumino; José María Huerta; Pilar Amiano; Miguel Rodriguez-Barranco; Catalina Bonet; Aurelio Barricarte; Sofia Christakoudi; Anika Knuppel; Bas Bueno-de-Mesquita; Matthias B Schulze; Rudolf Kaaks; Federico Canzian; Florentin Späth; Mats Jerkeman; Charlotta Rylander; Anne Tjønneland; Anja Olsen; Kristin Benjaminsen Borch; Roel Vermeulen
Journal:  Int J Cancer       Date:  2020-11-12       Impact factor: 7.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.